Literature DB >> 924734

Visual results following infantile cataract surgery.

D A Hiles, P H Wallar.   

Abstract

Aspiration and its modifications have been shown to be a superior operative procedure for neonatal, congenital, infantile, and acquired cataracts. However, the visual results obtained in the infantile cataractous eye, whether the opacity is complete or partial, still remain within the same range as the results of other operative techniques reported over the last 3 decades. Adequate visual results often cannot be obtained because of the associated systemic and/or ocular defects or failure of optical and amblyopia treatment. Perhaps increased efforts should be made to perform surgery at even earlier ages in those patients with complete, or in some cases, partial, cataracts in which surgery is contemplated. In children with partial cataracts who are able to function well, the lens should be allowed to remain in place and conservative measures of visual preservation should be undertaken for as long as possible. This allows the eye more time to develop normal visual functions with an intact lens and accommodative mechanisms. It should be stressed again that the sole success or failure of surgery for infantile cataracts cannot always be the visual acuity. The real measure is the child's ability to function successfully in his environment for the remainder of his life.

Entities:  

Mesh:

Year:  1977        PMID: 924734

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


  3 in total

1.  Outcome of treatment for bilateral congenital cataracts.

Authors:  R M Robb; R A Petersen
Journal:  Trans Am Ophthalmol Soc       Date:  1992

2.  Binocular visual form deprivation in human infants.

Authors:  I Mohindra; S G Jacobson; R Held
Journal:  Doc Ophthalmol       Date:  1983-05-01       Impact factor: 2.379

3.  Modulation of amblyopia therapy following early surgery for unilateral congenital cataracts.

Authors:  I C Lloyd; J G Dowler; A Kriss; L Speedwell; D A Thompson; I Russell-Eggitt; D Taylor
Journal:  Br J Ophthalmol       Date:  1995-09       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.